Results 111 to 120 of about 74,786 (193)

Event rates in major Phase 3 heart failure trials over the last 20 years. [PDF]

open access: yesESC Heart Fail
Aimo A   +5 more
europepmc   +1 more source

Tolerability of SGLT2 inhibitors in patients with Fabry disease: An observational study. [PDF]

open access: yesAm Heart J Plus
Mattig I   +7 more
europepmc   +1 more source

Research on the safety and efficacy of telitacicept in the treatment of IgA nephropathy in children. [PDF]

open access: yesRen Fail
Ying L   +10 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy